Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 172

The DOI matches its Crossref record.

Outcome of hematopoietic stem cell transplantation for adenosine deaminase–deficient severe combined immunodeficiency

Open access
Hassan, Amel, Booth, Claire, Brightwell, Alex, Allwood, Zoe, Veys, Paul, Rao, Kanchan, Hönig, Manfred, Friedrich, Wilhelm, Gennery, Andrew, Slatter, Mary, Bredius, Robbert, Finocchi, Andrea, Cancrini, Caterina, Aiuti, Alessandro, Porta, Fulvio, Lanfranchi, Arnalda, Ridella, Michela, Steward, Colin, Filipovich, Alexandra, Marsh, Rebecca, Bordon, Victoria, Al-Muhsen, Saleh, Al-Mousa, Hamoud, Alsum, Zobaida, Al-Dhekri, Hasan, Al Ghonaium, Abdulaziz, Speckmann, Carsten, Fischer, Alain, Mahlaoui, Nizar, Nichols, Kim E., Grunebaum, Eyal, Al Zahrani, Daifulah, Roifman, Chaim M., Boelens, Jaap, Davies, E. Graham, Cavazzana-Calvo, Marina, Notarangelo, Luigi, Gaspar, H. Bobby · 2012 · Blood

Abstract

Deficiency of the purine salvage enzyme adenosine deaminase leads to SCID (ADA-SCID). Hematopoietic cell transplantation (HCT) can lead to a permanent cure of SCID; however, little data are available on outcome of HCT for ADA-SCID in particular. In this multicenter retrospective study, we analyzed outcome of HCT in 106 patients with ADA-SCID who received a total of 119 transplants. HCT from matched sibling and family donors (MSDs, MFDs) had significantly better overall survival (86% and 81%) in comparison with HCT from matched unrelated (66%; P < .05) and haploidentical donors (43%; P < .001). Superior overall survival was also seen in patients who received unconditioned transplants in comparison with myeloablative procedures (81% vs 54%; P < .003), although in unconditioned haploidentical donor HCT, nonengraftment was a major problem. Long-term immune recovery showed that regardless of transplant type, overall T-cell numbers were similar, although a faster rate of T-cell recovery was observed after MSD/MFD HCT. Humoral immunity and donor B-cell engraftment was achieved in nearly all evaluable surviving patients and was seen even after unconditioned HCT. These data detail for the first time the outcomes of HCT for ADA-SCID and show that, if patients survive HCT, long-term cellular and humoral immune recovery is achieved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2011-12-396879

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 172

Metadata

Authors
Hassan, A., Booth, C., Brightwell, A., Allwood, Z., Veys, P., Rao, K., Hönig, M., Friedrich, W., Gennery, A., Slatter, M., Bredius, R., Finocchi, A., Cancrini, C., Aiuti, A., Porta, F., Lanfranchi, A., Ridella, M., Steward, C., Filipovich, A., Marsh, R., Bordon, V., Al-Muhsen, S., Al-Mousa, H., Alsum, Z., Al-Dhekri, H., Al Ghonaium, A., Speckmann, C., Fischer, A., Mahlaoui, N., Nichols, K. E., Grunebaum, E., Al Zahrani, D., Roifman, C. M., Boelens, J., Davies, E. G., Cavazzana-Calvo, M., Notarangelo, L., & Gaspar, H. B.
Venue
Blood
Published
2012-10-25
Volume
120
Issue
17
Pages
3615-3624
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1978660935
Cited by
172
References
0
FWCI
7.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcome of hematopoietic stem cell transplantation for adenosine deaminase–deficient severe combined immunodeficiency. https://app.cochat.ai/papers/10.1182/blood-2011-12-396879
The paper
Hassan, A., Booth, C., Brightwell, A., Allwood, Z., Veys, P., Rao, K., Hönig, M., Friedrich, W., Gennery, A., Slatter, M., Bredius, R., Finocchi, A., Cancrini, C., Aiuti, A., Porta, F., Lanfranchi, A., Ridella, M., Steward, C., Filipovich, A., . . . Gaspar, H. B. (2012). Outcome of hematopoietic stem cell transplantation for adenosine deaminase–deficient severe combined immunodeficiency. Blood. https://doi.org/10.1182/blood-2011-12-396879

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.